Published 20 hours ago • loading... • Updated 9 hours ago

Antidepressant Withdrawal, Not Relapse, Linked to Mood Changes

When people stop taking antidepressants, they can feel terrible—their mood can plummet and anxiety can spike. But are these symptoms caused by withdrawal, or are they signs of a relapse?

4 Articles

Medical Xpress

+3 Reposted by 3 other sources

Center

Antidepressant withdrawal, not relapse, linked to mood changes

When people stop taking antidepressants, they can feel terrible—their mood can plummet and anxiety can spike. But are these symptoms caused by withdrawal, or are they signs of a relapse?

10 hours ago·Douglas, United Kingdom

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Coverage Details

Total News Sources4

Leaning Left0Leaning Right0Center1Last Updated5 hours agoBias Distribution

100% Center

Bias Distribution

100% of the sources are Center

100% Center

Untracked bias

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Knowridge Science Report broke the news 20 hours ago on Monday, September 21, 2026.

Sources are mostly out of (0)

Antidepressant Withdrawal, Not Relapse, Linked to Mood Changes

4 Articles

4 Articles

Antidepressant withdrawal, not relapse, linked to mood changes

Coverage Details

Bias Distribution

Factuality

Ownership

More stories like this

Eli Lilly CEO tells CNBC one-third of new GLP-1 pill patients are taking Foundayo, as drugmaker ramps up production

Rare pregnancy infections linked to autism

Drugs, Anti-Obesity Semaglutide at the Center of the New Cardio-Renal Protection

Adonis Georgiadis: Bioequivalent Medicines at the Heart of the Greek EU Presidency in 2027 - iefimerida.gr

Merz: "Massive Problem" – What the Chancellor Means with His Sentence on Health Insurance

Novo stock falls as much as 7% despite $23 billion sales target for blockbuster obesity drugs

Similar News Topics

Similar News Topics

More stories like this

Eli Lilly CEO tells CNBC one-third of new GLP-1 pill patients are taking Foundayo, as drugmaker ramps up production

Rare pregnancy infections linked to autism

Drugs, Anti-Obesity Semaglutide at the Center of the New Cardio-Renal Protection

Adonis Georgiadis: Bioequivalent Medicines at the Heart of the Greek EU Presidency in 2027 - iefimerida.gr

Merz: "Massive Problem" – What the Chancellor Means with His Sentence on Health Insurance

Novo stock falls as much as 7% despite $23 billion sales target for blockbuster obesity drugs

Antidepressant Withdrawal, Not Relapse, Linked to Mood Changes

4 Articles

4 Articles

Antidepressant withdrawal, not relapse, linked to mood changes

Coverage Details

Bias Distribution Too Big Arrow Icon

Factuality Info Icon

Ownership

More stories like this

Eli Lilly CEO tells CNBC one-third of new GLP-1 pill patients are taking Foundayo, as drugmaker ramps up production

Rare pregnancy infections linked to autism

Drugs, Anti-Obesity Semaglutide at the Center of the New Cardio-Renal Protection

Adonis Georgiadis: Bioequivalent Medicines at the Heart of the Greek EU Presidency in 2027 - iefimerida.gr

Merz: "Massive Problem" – What the Chancellor Means with His Sentence on Health Insurance

Novo stock falls as much as 7% despite $23 billion sales target for blockbuster obesity drugs

Similar News Topics

Similar News Topics

More stories like this

Eli Lilly CEO tells CNBC one-third of new GLP-1 pill patients are taking Foundayo, as drugmaker ramps up production

Rare pregnancy infections linked to autism

Drugs, Anti-Obesity Semaglutide at the Center of the New Cardio-Renal Protection

Adonis Georgiadis: Bioequivalent Medicines at the Heart of the Greek EU Presidency in 2027 - iefimerida.gr

Merz: "Massive Problem" – What the Chancellor Means with His Sentence on Health Insurance

Novo stock falls as much as 7% despite $23 billion sales target for blockbuster obesity drugs

Bias Distribution

Factuality